Here are some of the recent references I have made about Biotechnology and the potential for a rally.
- AbbVie (NYSE:ABBV) as a top pick for 2025
- Novo Nordisk (NYSE:NVO) another top pick and subject of 2 recent Daily articles
- On Schwab Network Tuesday, Nicole and I discussed how this sector looked like it could perk up
- With Geoff Bysshe on Monday, we did a podcast featuring the Healthcare ETF and IBB, the Biotech ETF and part of the Economic Modern Family.
Incidentally, Moderna (NASDAQ:MRNA) is so oversold on a monthly timeframe, it should be on your radar.
How well is technical analysis (price) working right now? 
Looking right first, the chart of XLV shows the breakout over the 50-DMA back in early January.
If you are still not convinced our calendar ranges are amazing, look how that phase change perfectly corresponds with a breakout over the January 6-month calendar range!
Plus, another one of our incredible indicators, Real Motion showed a bullish divergence.
The chart on the left is IBB Biotechnology or what I call Big Brother of the Family as we all look to pharma to help and protect us.
Like XLV, Real Motion indicated a bullish divergence in momentum.
Exactly like XLV, that phase change over the 50-DMA corresponded with the January calendar range high.
Now both are trading above their 200-DMAs.
Plus, both are outperforming the benchmark.
I will say it again, technicals rule and fundamentals drool.
ETF Summary
(Pivotal means short-term bullish above that level and bearish below)
- S&P 500 (SPY) 600 support
- Russell 2000 (IWM) 227 now support and we watch again 230
- Dow (DIA) 439 support 452 now the resistance to clear
- Nasdaq (QQQ) 528 to clear
- Regional banks (KRE) 64 now the support to hold
- Semiconductors (SMH) Back over the 50-Week MA that now needs to hold
- Transportation (IYT) Its all about 68 support and getting back over 70
- Biotechnology (IBB) 140 now support to hold
- Retail (XRT) Needs to clear 81.
- iShares iBoxx Hi Yd Cor Bond ETF (HYG) Flashing risk on